ERLOLIEVA contains Erlotinib, an oral targeted anticancer medicine. It is a tyrosine kinase inhibitor (TKI) that selectively blocks the epidermal growth factor receptor (EGFR), thereby inhibiting tumor cell proliferation and survival—especially in EGFR-mutated cancers.
Key attributes
Category
ONCOLOGY
Brand
Allieva Pharma
Model number
ERLOLIEVA 150MG
Place of origin
Lucknow, UP, India
Certificates
ISO 9001
WHO-GMP Certified Company
Reviews
Questions & answers
Ask the supplier — answers are visible to all buyers